Abstracts
Résumé
L’agression impulsive a des conséquences négatives tant pour les personnes concernées que pour la société. Cette problématique est associée selon plusieurs chercheurs au système sérotoninergique. En psychiatrie, la violence impulsive se retrouve dans divers diagnostics de troubles mentaux. Le but de cet article est de faire une revue de la littérature sur les liens existants entre la sérotonine, les troubles mentaux et l’agression impulsive. Une attention particulière a été portée aux troubles mentaux graves telle la schizophrénie. Il ressort de l’étude des données actuelles que la sérotonine joue un rôle dans l’émergence des comportements violents et que ce fait transcende les catégories diagnostiques. Davantage de recherche serait toutefois nécessaire afin de déterminer le rôle de la sérotonine et les possibilités de traitements pouvant en découler.
Abstract
Impulsive aggression leads to various negative consequences for the individual and society. This problem was related to serotonergic system. Impulsive violence is also found in various diagnoses of mental disorders. The purpose of this paper is to present a review of the literature on the links between serotonin, mental disorders and impulsive aggression. Particular attention is devoted to serious mental disorders like schizophrenia. It appears that serotonin has a role in the emergence of violent behavior and that this can transcend diagnostic categories. More research will be necessary to determine the role of serotonin and treatment options that may arise.
Appendices
Bibliographie
- Amara, G., Richa, S., & Bayle, F. J. (2007). [Intermittent explosive disorder: current status]. Encephale, 33(3 Pt 1), 339-345.
- APA. (2000). Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC.: American Psychiatric Association.
- Askenazy, F., Caci, H., Myquel, M., Darcourt, G., & Lecrubier, Y. (2000). Relationship between impulsivity and platelet serotonin content in adolescents. Psychiatry Res, 94(1), 19-28.
- Biederman, J., Monuteaux, M. C., Mick, E., Spencer, T., Wilens, T. E., Silva, J. M., et al. (2006). Young adult outcome of attention deficit hyperactivity disorder: a controlled 10-year follow-up study. Psychol Med, 36(2), 167-179.
- Black, D. W., Blum, N., Pfohl, B., & Hale, N. (2004). Suicidal behavior in borderline personality disorder: prevalence, risk factors, prediction, and prevention. J Pers Disord, 18(3), 226-239.
- Brezo, J., Klempan, T., & Turecki, G. (2008). The genetics of suicide: a critical review of molecular studies. Psychiatr Clin North Am, 31(2), 179-203.
- Bymaster, F. P., Zhang, W., Carter, P. A., Shaw, J., Chernet, E., Phebus, L., et al. (2002). Fluoxetine, but not other selective serotonin uptake inhibitors, increases norepinephrine and dopamine extracellular levels in prefrontal cortex. Psychopharmacology (Berl), 160(4), 353-361.
- Canli, T., & Lesch, K. P. (2007). Long story short: the serotonin transporter in emotion regulation and social cognition. Nat Neurosci, 10(9), 1103-1109.
- Caspi, A., McClay, J., Moffitt, T. E., Mill, J., Martin, J., Craig, I. W., et al. (2002). Role of genotype in the cycle of violence in maltreated children. Science, 297(5582), 851-854.
- Clark, M. S., & Neumaier, J. F. (2001). The 5-HT1B receptor: behavioral implications. Psychopharmacol Bull, 35(4), 170-185.
- Clarke, R. A., Murphy, D. L., & Constantino, J. N. (1999). Serotonin and externalizing behavior in young children. Psychiatry Res, 86(1), 29-40.
- Coccaro, E. F. (1989). Central serotonin and impulsive aggression. Br J Psychiatry Suppl(8), 52-62.
- Coccaro, E. F., & Kavoussi, R. J. (1997). Fluoxetine and impulsive aggressive behavior in personality-disordered subjects. Arch Gen Psychiatry, 54(12), 1081-1088.
- Coccaro, E. F., Lee, R. J., & Kavoussi, R. J. (2009). A double-blind, randomized, placebo-controlled trial of fluoxetine in patients with intermittent explosive disorder. J Clin Psychiatry.
- Coccaro, E. F., Schmidt, C. A., Samuels, J. F., & Nestadt, G. (2004). Lifetime and 1-month prevalence rates of intermittent explosive disorder in a community sample. J Clin Psychiatry, 65(6), 820-824.
- Constantino, J. N., Morris, J. A., & Murphy, D. L. (1997). CSF 5-HIAA and family history of antisocial personality disorder in newborns. Am J Psychiatry, 154(12), 1771-1773.
- Constantino, J. N., Murphy, D. L., & Morris, J. A. (1999). Family psychiatric history, cerebrospinal fluid monoamine metabolites, and temperament in infants. Biol Psychiatry, 45(5), 626-632.
- de Boer, S. F., & Koolhaas, J. M. (2005). 5-HT1A and 5-HT1B receptor agonists and aggression: a pharmacological challenge of the serotonin deficiency hypothesis. Eur J Pharmacol, 526(1-3), 125-139.
- Douglas, K. S., Guy, L. S., & Hart, S. D. (2009). Psychosis as a risk factor for violence to others: a meta-analysis. Psychol Bull, 135(5), 679-706.
- Dubreucq, J. L., Joyal, C. C., & Millaud, F. (2005). Risque de violence et troubles mentaux graves. Annales Médico Psychologiques(163), 852–865.
- Elbogen, E. B., & Johnson, S. C. (2009). The intricate link between violence and mental disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry, 66(2), 152-161.
- Fazel, S., & Grann, M. (2004). Psychiatric morbidity among homicide offenders: a Swedish population study. Am J Psychiatry, 161(11), 2129-2131.
- Goedhard, L. E., Stolker, J. J., Heerdink, E. R., Nijman, H. L., Olivier, B., & Egberts, T. C. (2006). Pharmacotherapy for the treatment of aggressive behavior in general adult psychiatry: A systematic review. J Clin Psychiatry, 67(7), 1013-1024.
- Gottesman, II, & Gould, T. D. (2003). The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry, 160(4), 636-645.
- Hercigonja Novkovic, V., Rudan, V., Pivac, N., Nedic, G., & Muck-Seler, D. (2009). Platelet serotonin concentration in children with attention-deficit/hyperactivity disorder. Neuropsychobiology, 59(1), 17-22.
- Hodgins, S. (1992). Mental disorder, intellectual deficiency, and crime. Evidence from a birth cohort. Arch Gen Psychiatry, 49(6), 476-483.
- Hodgins, S. (2008). Review. Violent behaviour among people with schizophrenia: a framework for investigations of causes, and effective treatment, and prevention. Philos Trans R Soc Lond B Biol Sci, 363(1503), 2505-2518.
- Hodgins, S., Cree, A., Alderton, J., & Mak, T. (2007). From conduct disorder to severe mental illness: associations with aggressive behaviour, crime and victimization. Psychol Med, 1-13.
- Jacob, C. P., Muller, J., Schmidt, M., Hohenberger, K., Gutknecht, L., Reif, A., et al. (2005). Cluster B personality disorders are associated with allelic variation of monoamine oxidase A activity. Neuropsychopharmacology, 30(9), 1711-1718.
- Joyal, C., Dubreucq, J. L., Gendron, C., & Millaud, F. (2007). Major Mental Disorders and Violence: A Critical Update Current Psychiatry Reviews, 3, 33-50.
- Karere, G. M., Kinnally, E. L., Sanchez, J. N., Famula, T. R., Lyons, L. A., & Capitanio, J. P. (2009). What is an "adverse" environment? Interactions of rearing experiences and MAOA genotype in rhesus monkeys. Biol Psychiatry, 65(9), 770-777.
- Kendler, K. S., Aggen, S. H., Czajkowski, N., Roysamb, E., Tambs, K., Torgersen, S., et al. (2008). The structure of genetic and environmental risk factors for DSM-IV personality disorders: a multivariate twin study. Arch Gen Psychiatry, 65(12), 1438-1446.
- Kessler, R. C., Coccaro, E. F., Fava, M., Jaeger, S., Jin, R., & Walters, E. (2006). The prevalence and correlates of DSM-IV intermittent explosive disorder in the National Comorbidity Survey Replication. Arch Gen Psychiatry, 63(6), 669-678.
- Kinnally, E. L., Huang, Y. Y., Haverly, R., Burke, A. K., Galfalvy, H., Brent, D. P., et al. (2009). Parental care moderates the influence of MAOA-uVNTR genotype and childhood stressors on trait impulsivity and aggression in adult women. Psychiatr Genet.
- Krakowski, M. I., Czobor, P., Citrome, L., Bark, N., & Cooper, T. B. (2006). Atypical antipsychotic agents in the treatment of violent patients with schizophrenia and schizoaffective disorder. Arch Gen Psychiatry, 63(6), 622-629.
- Krakowski, M. I., Czobor, P., & Nolan, K. A. (2008). Atypical antipsychotics, neurocognitive deficits, and aggression in schizophrenic patients. J Clin Psychopharmacol, 28(5), 485-493.
- Lee, R., Kavoussi, R. J., & Coccaro, E. F. (2008). Placebo-controlled, randomized trial of fluoxetine in the treatment of aggression in male intimate partner abusers. Int Clin Psychopharmacol, 23(6), 337-341.
- Lesch, K. P., & Merschdorf, U. (2000). Impulsivity, aggression, and serotonin: a molecular psychobiological perspective. Behav Sci Law, 18(5), 581-604.
- Leschied, A., Chiodo, D., Nowicki, E., & Rodger, S. (2008). Childhood Predictors of Adult Criminality: A Meta-Analysis Drawn from the Prospective Longitudinal Literature. Canadian Journal of Criminology and Criminal Justice, 50(4), 435-467.
- Mann, J. J., Arango, V. A., Avenevoli, S., Brent, D. A., Champagne, F. A., Clayton, P., et al. (2009). Candidate endophenotypes for genetic studies of suicidal behavior. Biol Psychiatry, 65(7), 556-563.
- McCloskey, M. S., Ben-Zeev, D., Lee, R., Berman, M. E., & Coccaro, E. F. (2009). Acute tryptophan depletion and self-injurious behavior in aggressive patients and healthy volunteers. Psychopharmacology (Berl), 203(1), 53-61.
- McCloskey, M. S., Berman, M. E., Noblett, K. L., & Coccaro, E. F. (2006). Intermittent explosive disorder-integrated research diagnostic criteria: convergent and discriminant validity. J Psychiatr Res, 40(3), 231-242.
- Minzenberg, M. J., & Siever, L. J. (2006). Neurochemistry and Pharmacology of Psychopathy and Related Disorders. In C. J. Patrick (Ed.), Handbook of Psychopathy (Vol. 251-277). New-York: The Guilford Press.
- Monahan, Steadman, H. J., Silver, E., Appelbaum, P. S., Robbins, P. C., Mulvey, E. P., et al. (2001). Rethinking Risk Assessment The MacArthur Study of Mental Disorder and Violence. New-York: Oxford University Press.
- Monahan, & Swanson. (1994). Violence and Mental disorder, Developments in Risk Assessment. Chicago and London: The university of Chicago Press.
- Mueser, K. T., Crocker, A. G., Frisman, L. B., Drake, R. E., Covell, N. H., & Essock, S. M. (2006). Conduct disorder and antisocial personality disorder in persons with severe psychiatric and substance use disorders. Schizophr Bull, 32(4), 626-636.
- Mullen, P. E., Burgess, P., Wallace, C., Palmer, S., & Ruschena, D. (2000). Community care and criminal offending in schizophrenia. Lancet, 355(9204), 614-617.
- New, A. S., Buchsbaum, M. S., Hazlett, E. A., Goodman, M., Koenigsberg, H. W., Lo, J., et al. (2004). Fluoxetine increases relative metabolic rate in prefrontal cortex in impulsive aggression. Psychopharmacology (Berl), 176(3-4), 451-458.
- Nomura, M., & Nomura, Y. (2006). Psychological, neuroimaging, and biochemical studies on functional association between impulsive behavior and the 5-HT2A receptor gene polymorphism in humans. Ann N Y Acad Sci, 1086, 134-143.
- Oades, R. D. (2008). Dopamine-serotonin interactions in attention-deficit hyperactivity disorder (ADHD). Prog Brain Res, 172, 543-565.
- Odgers, C. L., Caspi, A., Broadbent, J. M., Dickson, N., Hancox, R. J., Harrington, H., et al. (2007). Prediction of differential adult health burden by conduct problem subtypes in males. Arch Gen Psychiatry, 64(4), 476-484.
- Odgers, C. L., Moffitt, T. E., Broadbent, J. M., Dickson, N., Hancox, R. J., Harrington, H., et al. (2008). Female and male antisocial trajectories: from childhood origins to adult outcomes. Dev Psychopathol, 20(2), 673-716.
- OMS. (2002). Rapport mondial sur la violence et la santé. Genève: Organisation mondiale de la santé.
- Pesonen, U., Koulu, M., Bergen, A., Eggert, M., Naukkarinen, H., Virkkunen, M., et al. (1998). Mutation screening of the 5-hydroxytryptamine7 receptor gene among Finnish alcoholics and controls. Psychiatry Res, 77(3), 139-145.
- Polanczyk, G., de Lima, M. S., Horta, B. L., Biederman, J., & Rohde, L. A. (2007). The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry, 164(6), 942-948.
- Rothman, R. B., & Baumann, M. H. (2002). Serotonin releasing agents. Neurochemical, therapeutic and adverse effects. Pharmacol Biochem Behav, 71(4), 825-836.
- Roy, A., Virkkunen, M., & Linnoila, M. (1988). Monoamines, glucose metabolism, aggression towards self and others. Int J Neurosci, 41(3-4), 261-264.
- Siegel, A., Bhatt, S., Bhatt, R., & Zalcman, S. S. (2007). The neurobiological bases for development of pharmacological treatments of aggressive disorders. Curr Neuropharmacol, 5(2), 135-147.
- Siever, L. J. (2008). Neurobiology of aggression and violence. Am J Psychiatry, 165(4), 429-442.
- Siever, L. J., Buchsbaum, M. S., New, A. S., Spiegel-Cohen, J., Wei, T., Hazlett, E. A., et al. (1999). d,l-fenfluramine response in impulsive personality disorder assessed with [18F]fluorodeoxyglucose positron emission tomography. Neuropsychopharmacology, 20(5), 413-423.
- Simon, V., Czobor, P., Balint, S., Meszaros, A., & Bitter, I. (2009). Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis. Br J Psychiatry, 194(3), 204-211.
- Stahl, S. M. (2008). Stahl's Essential Psychopharmacology: Neuroscientific Basis and Practical Applications. Third Edition. New-York: Cambridge University Press.
- Tiihonen, J., Isohanni, M., Rasanen, P., Koiranen, M., & Moring, J. (1997). Specific major mental disorders and criminality: a 26-year prospective study of the 1966 northern Finland birth cohort. Am J Psychiatry, 154(6), 840-845.
- Volavka, J., & Nolan, K. A. (2008). Methodological structure for aggression research. Psychiatr Q, 79(4), 293-300.
- Wallace, C., Mullen, P. E., & Burgess, P. (2004). Criminal offending in schizophrenia over a 25-year period marked by deinstitutionalization and increasing prevalence of comorbid substance use disorders. Am J Psychiatry, 161(4), 716-727.
- Witte, A. V., Floel, A., Stein, P., Savli, M., Mien, L. K., Wadsak, W., et al. (2008). Aggression is related to frontal serotonin-1A receptor distribution as revealed by PET in healthy subjects. Hum Brain Mapp.